Jumpei Izuka

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
OBJECTIVE The present study aimed to evaluate the influence of the magnitude of best tumor shrinkage during second-line targeted therapy after first-line tyrosine kinase inhibitor failure on metastatic renal cell carcinoma prognosis. METHODS Fifty-two patients were enrolled. The magnitude of tumor shrinkage was assessed according to the Response(More)
  • 1